Double-blind, randomised, placebo-controlled study of leflunomide in the treatment of active ankylosing spondylitis

被引：0
|
作者：
Van Denderen, JC
Van der Paardt, M
Nurmohamed, MT
De Ryck, YM
Dijkmans, BAC
Van der Horst-Bruinsma, IE
机构：
[1] Jan van Breemen Inst, Amsterdam, Netherlands
[2] Aventis, Pharma, Hoevelaken, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：397 / 397
页数：1
相关论文
共 50 条
  • [1] Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis
    van Denderen, JC
    van der Paardt, M
    Nurmohamed, MT
    de Ryck, YMMA
    Dijkmans, BAC
    van der Horst-Bruinsma, IE
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (12) : 1761 - 1764
  • [2] Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
    Deodhar, Atul
    Sliwinska-Stanczyk, Paula
    Xu, Huji
    Baraliakos, Xenofon
    Gensler, Lianne S.
    Fleishaker, Dona
    Wang, Lisy
    Wu, Joseph
    Menon, Sujatha
    Wang, Cunshan
    Dina, Oluwaseyi
    Fallon, Lara
    Kanik, Keith S.
    van der Heijde, Desiree
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (08) : 1004 - 1013
  • [3] Sarilumab for the treatment of ankylosing spondylitis: results of a Phase II, randomised, double-blind, placebo-controlled study (ALIGN)
    Sieper, Joachim
    Braun, Juergen
    Kay, Jonathan
    Badalamenti, Salvatore
    Radin, Allen R.
    Jiao, Lixia
    Fiore, Stefano
    Momtahen, Tanya
    Yancopoulos, George D.
    Stahl, Neil
    Inman, Robert D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (06) : 1051 - 1057
  • [4] Etanercept in the treatment of ankylosing spondylitis: A randomized, double-blind, placebo-controlled study.
    Gorman, JD
    Sack, KE
    Davis, JC
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S403 - S403
  • [5] Randomised, Double-blind, Placebo-controlled Study of Iguratimod in the Treatment of Active Spondyloarthritis
    Li, Yan
    Li, Kunpeng
    Zhao, Zheng
    Wang, Yanyan
    Jin, Jingyu
    Zhang, Jianglin
    Zhu, Jian
    Huang, Feng
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3787 - 3788
  • [6] Randomised, Double-Blind, Placebo-Controlled Study of Iguratimod in the Treatment of Active Spondyloarthritis
    Li, Yan
    Li, Kunpeng
    Zhao, Zheng
    Wang, Yanyan
    Jin, Jingyu
    Guo, Junhua
    Zhang, Jie
    Zhang, Jianglin
    Zhu, Jian
    Huang, Feng
    [J]. FRONTIERS IN MEDICINE, 2021, 8
  • [7] Methotrexate in severe ankylosing spondylitis: a randomised placebo controlled, double-blind observer study
    Roychowdhury, B.
    Bintley-Bagot, S.
    Hunt, J.
    Tunn, E. J.
    [J]. RHEUMATOLOGY, 2001, 40 : 43 - 43
  • [8] A randomized, double-blind, placebo-controlled trial of (Enbrel®) in the treatment of Ankylosing Spondylitis.
    Gorman, JD
    Sack, KE
    Davis, JC
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S90 - S90
  • [9] Efficacy of etanercept (Enbrel®) in the treatment of ankylosing spondylitis:: A randomized, placebo-controlled, double-blind study.
    Gorman, JD
    Sack, KE
    Davis, JC
    [J]. ARTHRITIS AND RHEUMATISM, 2001, 44 (12): : 2947 - 2947
  • [10] Efficacy of oral prednisolone in active ankylosing spondylitis: results of a double-blind, randomised, placebo-controlled short-term trial
    Haibel, H.
    Fendler, C.
    Listing, J.
    Callhoff, J.
    Braun, J.
    Sieper, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 243 - 246
12345